These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15897582)

  • 21. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
    Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
    Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
    Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sendai virus-mediated CFTR gene transfer to the airway epithelium.
    Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; You J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW
    Gene Ther; 2007 Oct; 14(19):1371-9. PubMed ID: 17597790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of HSV mass distribution in a rodent brain tumor model.
    Schellingerhout D; Rainov NG; Breakefield XO; Weissleder R
    Gene Ther; 2000 Oct; 7(19):1648-55. PubMed ID: 11083473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.
    Nakamura K; Ito Y; Kawano Y; Kurozumi K; Kobune M; Tsuda H; Bizen A; Honmou O; Niitsu Y; Hamada H
    Gene Ther; 2004 Jul; 11(14):1155-64. PubMed ID: 15141157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells.
    Jin CH; Kusuhara K; Yonemitsu Y; Nomura A; Okano S; Takeshita H; Hasegawa M; Sueishi K; Hara T
    Gene Ther; 2003 Feb; 10(3):272-7. PubMed ID: 12571635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total vascular exclusion of the liver enhances the efficacy of retroviral-mediated associated thymidine kinase and interleukin-2 genes transfer against multiple hepatic tumors in rats.
    Alves A; Charre L; Panis Y; Cardoso J; Fabre M; Brisson E; Houssin D; Soubrane O; Klatzmann D
    Surgery; 2003 Jun; 133(6):669-77. PubMed ID: 12796736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils.
    Shirakura M; Inoue M; Fujikawa S; Washizawa K; Komaba S; Maeda M; Watabe K; Yoshikawa Y; Hasegawa M
    Gene Ther; 2004 May; 11(9):784-90. PubMed ID: 14961067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector.
    Rainov NG; Dobberstein KU; Heidecke V; Dorant U; Chase M; Kramm CM; Chiocca EA; Breakefield XO
    Cancer Gene Ther; 1998; 5(3):158-62. PubMed ID: 9622099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sendai virus transgene in a novel gene therapy for laryngotracheal disease.
    Mizokami D; Araki K; Tanaka N; Suzuki H; Tomifuji M; Yamashita T; Inoue M; Hasegawa M; Shiotani A
    Laryngoscope; 2013 Jul; 123(7):1717-24. PubMed ID: 23666749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector.
    Shiotani A; Fukumura M; Maeda M; Hou X; Inoue M; Kanamori T; Komaba S; Washizawa K; Fujikawa S; Yamamoto T; Kadono C; Watabe K; Fukuda H; Saito K; Sakai Y; Nagai Y; Kanzaki J; Hasegawa M
    Gene Ther; 2001 Jul; 8(14):1043-50. PubMed ID: 11526451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of optimized and urokinase-targeted oncolytic Sendai virus vectors applicable for various human malignancies.
    Kinoh H; Inoue M; Komaru A; Ueda Y; Hasegawa M; Yonemitsu Y
    Gene Ther; 2009 Mar; 16(3):392-403. PubMed ID: 19037241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells.
    Hosoya N; Miura T; Kawana-Tachikawa A; Koibuchi T; Shioda T; Odawara T; Nakamura T; Kitamura Y; Kano M; Kato A; Hasegawa M; Nagai Y; Iwamoto A
    J Med Virol; 2008 Mar; 80(3):373-82. PubMed ID: 18205221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of recombinant Sendai virus in a non-natural host model.
    Griesenbach U; McLachlan G; Owaki T; Somerton L; Shu T; Baker A; Tennant P; Gordon C; Vrettou C; Baker E; Collie DD; Hasegawa M; Alton EW
    Gene Ther; 2011 Feb; 18(2):182-8. PubMed ID: 20962870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
    Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
    Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant Sendai virus vectors for activated T lymphocytes.
    Okano S; Yonemitsu Y; Nagata S; Sata S; Onimaru M; Nakagawa K; Tomita Y; Kishihara K; Hashimoto S; Nakashima Y; Sugimachi K; Hasegawa M; Sueishi K
    Gene Ther; 2003 Aug; 10(16):1381-91. PubMed ID: 12883535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy.
    Kruse CA; Visonneau S; Kleinschmidt-DeMasters BK; Gup CJ; Gomez GG; Paul DB; Santoli D
    Cancer Res; 2000 Oct; 60(20):5731-9. PubMed ID: 11059767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates.
    Yang WQ; Lun X; Palmer CA; Wilcox ME; Muzik H; Shi ZQ; Dyck R; Coffey M; Thompson B; Hamilton M; Nishikawa SG; Brasher PM; Fonseca K; George D; Rewcastle NB; Johnston RN; Stewart D; Lee PW; Senger DL; Forsyth PA
    Clin Cancer Res; 2004 Dec; 10(24):8561-76. PubMed ID: 15623640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes.
    Tashiro H; Aoki M; Isobe M; Hashiya N; Makino H; Kaneda Y; Ogihara T; Morishita R
    J Mol Cell Cardiol; 2005 Sep; 39(3):503-9. PubMed ID: 16040050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.